康泰醫學(300869.SZ):完成醫療器械註冊證變更登記及取得1項醫療器械註冊證
格隆匯 12 月 10日丨康泰醫學(300869.SZ)公佈,公司於近日收到由河北省藥品監督管理局頒發的1項《醫療器械註冊證變更文件》,產品名稱為臂式電子血壓計。公司於近期收到了由河北省藥品監督管理局頒發的1項《醫療器械註冊證》,產品名稱為血氧心電設備數據管理軟件。
上述醫療器械註冊證變更後,豐富了公司現有臂式電子血壓計的型號,進一步增強公司產品的綜合競爭力和市場拓展能力。上述新註冊證的取得,是對公司現有產品的有效補充,有利於提高公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.